MSI-low, a real phenomenon which varies in frequency among cancer types

被引:47
作者
Halford, SER
Sawyer, EJ
Lambros, MB
Gorman, P
Macdonald, ND
Talbot, IC
Foulkes, WD
Gillett, CE
Barnes, DM
Akslen, LA
Lee, K
Jacobs, IJ
Hanby, AM
Ganesan, TS
Salvesen, HB
Bodmer, WF
Tomlinson, IP
Roylance, RR
机构
[1] Canc Res UK, Mol & Populat Genet Lab, London WC2A 3PX, England
[2] Canc Res UK, Canc & Immunogenet Lab, London WC2A 3PX, England
[3] John Radcliffe Hosp, Inst Mol Med, Oxford OX3 9DZ, England
[4] St Bartholomews Hosp, Gynaecol Canc Res Unit, Dept Gynecol Oncol, London, England
[5] Royal London Hosp, Sch Med & Dent, London, England
[6] St Marks Hosp, Acad Dept Pathol, Harrow HA1 3UJ, Middx, England
[7] St Marks Hosp, Canc Res UK, Harrow HA1 3UJ, Middx, England
[8] McGill Univ, Dept Human Genet, Montreal, PQ H3G 1A4, Canada
[9] Guys Hosp, Hedley Atkins Canc Res UK, Breast Pathol Lab, London SE1 9RT, England
[10] Haukeland Hosp, Gade Inst, Dept Obstet & Gynaecol, N-5021 Bergen, Norway
[11] Haukeland Hosp, Gade Inst, Dept Pathol, N-5021 Bergen, Norway
[12] John Radcliffe Hosp, ICRF Mol Oncol Labs, Oxford OX3 9DS, England
[13] St James Hosp, ICRF Dept Histopathol, Leeds LS9 7TF, W Yorkshire, England
关键词
microsatellite instability; MSI-low; MSI-L; colorectal cancer; ovarian cancer; breast cancer; endometrial cancer; HNPCC;
D O I
10.1002/path.1453
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This study assessed whether low-level microsatellite instability (MSI-L) is a phenomenon. specific to colorectal cancers or is also present in other tumour types. Breast (grade III ductal and lobular), endometrial and ovarian carcinomas, as well as colorectal cancers, were analysed for MSI-L using eight microsatellite markers. The markers were selected from a panel that had previously been shown to be sensitive for the detection of MSI-L in colorectal cancers. It was found that MSI-L was present in 30 of 87 (35%) colorectal cancers, 2 of 59 (3%) grade III breast carcinomas, 1 of 35 (3%) lobular breast cancers, 16 of 50 (32%) endometrial cancers, and 9 of 34 (26%) ovarian cancers. These results suggest that MSI-L is a very rare occurrence in breast carcinomas, but does occur as a real phenomenon in colorectal, endometrial, and ovarian carcinomas, which are all part of the hereditary non-polyposis colon cancer (HNPCC) syndrome. PCR artefact was also found to masquerade as MSI-L; criteria for the assessment of MSI-L are suggested to eliminate this problem. Copyright (C) 2003 John Wiley Sons, Ltd.
引用
收藏
页码:389 / 394
页数:6
相关论文
共 30 条
[1]   Microsatellite instability in ovarian and other pelvic carcinomas [J].
Allen, HJ ;
DiCioccio, RA ;
Hohmann, P ;
Piver, MS ;
Tworek, H .
CANCER GENETICS AND CYTOGENETICS, 2000, 117 (02) :163-166
[2]  
Anbazhagan R, 1999, CLIN CANCER RES, V5, P839
[3]   Alteration of hMSH2 and DNA polymerase β genes in breast carcinomas and fibroadenomas [J].
Bhattacharyya, N ;
Chen, HC ;
Grundfest-Broniatowski, S ;
Banerjee, S .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 259 (02) :429-435
[4]  
Boland CR, 1998, CANCER RES, V58, P5248
[5]  
Caduff RF, 1996, AM J PATHOL, V148, P1671
[6]  
Caldés T, 2000, TERATOGEN CARCIN MUT, V20, P283, DOI 10.1002/1520-6866(2000)20:5<283::AID-TCM4>3.3.CO
[7]  
2-P
[8]  
Caldés T, 2000, INT J ONCOL, V16, P1235
[9]   FREQUENT LOSS OF HETEROZYGOSITY ON CHROMOSOME-6 IN HUMAN OVARIAN-CARCINOMA [J].
FOULKES, WD ;
RAGOUSSIS, J ;
STAMP, GWH ;
ALLAN, GJ ;
TROWSDALE, J .
BRITISH JOURNAL OF CANCER, 1993, 67 (03) :551-559
[10]  
Halford S, 2002, CANCER RES, V62, P53